Qelbree

Generic name: Viloxazine

Drug class: Adrenergic uptake inhibitors for ADHD

Dosage forms: Extended-release capsules

Root of administration: Oral

Dose: 100, 150, 200 mg

Mechanism of action: Qelbree (viloxazine hydrochloride) is a medication that is used for the treatment of attention deficit hyperactivity disorder (ADHD) in pediatric patients aged 6 to 17 years.

Drug usage cases: It is used in cases where non-pharmacological interventions alone may be insufficient. Qelbree is specifically indicated for the management of ADHD symptoms, including hyperactivity, impulsivity, and inattention. It is not a stimulant medication like many other commonly prescribed ADHD medications. The usage of Qelbree is typically considered when the healthcare professional determines that non-pharmacological interventions, such as behavioral therapy or educational interventions, have not provided adequate symptom control or when stimulant medications are not suitable for the patient due to contraindications or intolerance.

Drug contra indications: Before starting treatment, tell your healthcare provider about all you or your child’s medical conditions, including if you or your child:

has, or has a family history of, suicide, bipolar disorder, depression, mania or hypomania, has blood pressure or heart rate problems, has severe kidney problems. Your healthcare provider may lower the dose. has liver problems

Side effects: Qelbree can cause serious side effects, including:

See Important information, Increased blood pressure and heart rate. Your healthcare provider should check you or your child’s blood pressure and heart rate before starting and during treatment. Manic episodes. Manic episodes may happen in people with bipolar disorder who take Qelbree. Symptoms may include:

greatly increased energy, racing thoughts, unusually grand ideas, talking more or faster than usual, severe trouble sleeping, reckless behavior, excessive happiness or irritability, Sleepiness and tiredness.

Warnings: It is not known if this medicine is safe and effective in children less than 6 years of age.

Use during pregnancy or breastfeeding: is pregnant or plans to become pregnant. Qelbree may cause harm to the mother when taken during pregnancy. You and your healthcare provider will decide if Qelbree should be taken during pregnancy. Tell your healthcare provider right away if you or your child become pregnant or think they are pregnant during treatment with Qelbree. There is a pregnancy registry for females who are exposed to Qelbree during pregnancy. The purpose of the registry is to collect information about the health of females exposed to Qelbree and their baby. If you become pregnant while taking Qelbree, talk to your healthcare provider about it. is breastfeeding or plans to breastfeed. It is not known if Qelbree passes into breastmilk. Talk to your healthcare provider about the best way to feed the baby during treatment. potential risks before taking this medication while breastfeeding.